SVA POTENTIAL TO HAVE $96 Million in CashWarrants:
25M in Aug & Sept $ 8M at 30-35 cents, a for sure deal
20M March @ 1.70 34M accelerate upon $3.05 per share
Evotec 27M
Cash as at Jan 31 27M
Total $96M
That should get the attention of Big Pharma + Analysts recommending SVA, all
with targets over $3.00. We have the most beautiful Chart with a Fibonacci screaming
for a weekly close over $1.60 so the stock can reach next target of Minimum $3.75,
and ideally it should go to the 1.618 extension which is all the way up to $5.50.
The Scientists have performed - now it is time for the I.R. guys to perform, they have
been given a gift on a silver platter - if they don't soon get this stock on a weekly close
above $1.60 - Big Pharma will take us out for a song. The iPSC DEAL should be
worth another $1B to SVA and our stock sits at $1.46. SOMETHING IS WRONG.
Don;t take my word, look at the Chart, ask your buddies who participate in Fibonacci.